CA2952818A1 - Compositions pour le traitement de l'epistaxis - Google Patents
Compositions pour le traitement de l'epistaxis Download PDFInfo
- Publication number
- CA2952818A1 CA2952818A1 CA2952818A CA2952818A CA2952818A1 CA 2952818 A1 CA2952818 A1 CA 2952818A1 CA 2952818 A CA2952818 A CA 2952818A CA 2952818 A CA2952818 A CA 2952818A CA 2952818 A1 CA2952818 A1 CA 2952818A1
- Authority
- CA
- Canada
- Prior art keywords
- composition
- group
- phenylephrine
- combinations
- water
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Otolaryngology (AREA)
- Pulmonology (AREA)
- Emergency Medicine (AREA)
- Inorganic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/IB2015/001451 WO2016178053A1 (fr) | 2015-05-01 | 2015-05-01 | Compositions pour le traitement de l'epistaxis |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2952818A1 true CA2952818A1 (fr) | 2016-11-10 |
Family
ID=57218149
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA2952818A Abandoned CA2952818A1 (fr) | 2015-05-01 | 2015-05-01 | Compositions pour le traitement de l'epistaxis |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP3288636A4 (fr) |
CN (1) | CN107073293A (fr) |
CA (1) | CA2952818A1 (fr) |
IL (1) | IL249640A0 (fr) |
WO (1) | WO2016178053A1 (fr) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11724985B2 (en) | 2020-05-19 | 2023-08-15 | Cybin Irl Limited | Deuterated tryptamine derivatives and methods of use |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX2019011873A (es) * | 2017-04-04 | 2019-11-21 | Anti Plasmin Tech Llc | Composiciones y metodos para mejorar un tratamiento medico no quirurgico. |
GB2571696B (en) | 2017-10-09 | 2020-05-27 | Compass Pathways Ltd | Large scale method for the preparation of Psilocybin and formulations of Psilocybin so produced |
EP3955918A1 (fr) | 2019-04-17 | 2022-02-23 | COMPASS Pathfinder Limited | Procédés pour traiter les troubles neurocognitifs, la douleur chronique, et pour réduire l'inflammation |
US11654057B2 (en) | 2020-04-09 | 2023-05-23 | Bio 54, Llc | Devices for bleeding reduction and methods of making and using the same |
US11642324B1 (en) * | 2022-03-01 | 2023-05-09 | Bio 54, Llc | Topical tranexamic acid compositions and methods of use thereof |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040235807A1 (en) * | 2003-05-21 | 2004-11-25 | Weinrich Karl P. | Formulations including a topical decongestant and a topical corticosteroid suitable for nasal administration and method for treating obstructive sleep apnea |
US8022106B2 (en) * | 2004-03-04 | 2011-09-20 | Ferring B.V. | Tranexamic acid formulations |
RU2369408C2 (ru) * | 2004-07-09 | 2009-10-10 | Ферросан А/С | Гемостатическая композиция, включающая гиалуроновую кислоту |
ES2752008T3 (es) * | 2009-10-30 | 2020-04-02 | Intratus Inc | Métodos y composiciones para la liberación sostenida de fármacos |
WO2014064703A1 (fr) * | 2012-10-28 | 2014-05-01 | Peritech Pharma Ltd. | Compositions adhésives liquides pharmaceutiques pour le traitement de troubles anorectaux |
EP2968133A4 (fr) * | 2013-03-10 | 2016-03-09 | Peritech Pharma Ltd | Compositions topiques et procédés de traitement de troubles topiques |
-
2015
- 2015-05-01 CA CA2952818A patent/CA2952818A1/fr not_active Abandoned
- 2015-05-01 EP EP15891259.2A patent/EP3288636A4/fr not_active Withdrawn
- 2015-05-01 CN CN201580036043.8A patent/CN107073293A/zh active Pending
- 2015-05-01 WO PCT/IB2015/001451 patent/WO2016178053A1/fr active Application Filing
-
2016
- 2016-12-19 IL IL249640A patent/IL249640A0/en unknown
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11724985B2 (en) | 2020-05-19 | 2023-08-15 | Cybin Irl Limited | Deuterated tryptamine derivatives and methods of use |
US11746088B2 (en) | 2020-05-19 | 2023-09-05 | Cybin Irl Limited | Deuterated tryptamine derivatives and methods of use |
US11834410B2 (en) | 2020-05-19 | 2023-12-05 | Cybin Irl Limited | Deuterated tryptamine derivatives and methods of use |
US11958807B2 (en) | 2020-05-19 | 2024-04-16 | Cybin Irl Limited | Deuterated tryptamine derivatives and methods of use |
Also Published As
Publication number | Publication date |
---|---|
WO2016178053A1 (fr) | 2016-11-10 |
IL249640A0 (en) | 2017-02-28 |
EP3288636A4 (fr) | 2019-01-16 |
EP3288636A1 (fr) | 2018-03-07 |
CN107073293A (zh) | 2017-08-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10085995B2 (en) | Topical compositions and methods of treatment of anorectal disorders | |
CA2952818A1 (fr) | Compositions pour le traitement de l'epistaxis | |
JP6267218B2 (ja) | 揮発性、疎水性溶媒を用いた生物学的に活性な薬剤の送達 | |
RU2754846C1 (ru) | Обезболивающие композиции местного действия | |
JP6093007B2 (ja) | 基質に有効成分を送達するためのシリコーン系賦形剤を含有する局所用製剤組成物 | |
JP2012532222A (ja) | 膜形成シリコーン含有組成物 | |
JP2007509954A (ja) | 局所的な適用のための徐放性の組成物及び基体へ活性な作用薬を配送する方法 | |
US20150231300A1 (en) | Pharmaceutical liquid adhesive compositions for treatment of anorectal disorders | |
US20150366798A1 (en) | Pharmaceutical adhesive compositions for treatment of epistaxis and methods of use thereof | |
JP2008534483A (ja) | 経皮局所用組成物およびその使用 | |
ES2875381T3 (es) | Formulación tópica | |
JP2018177724A (ja) | 外用薬 | |
JP5241104B2 (ja) | 外用組成物 | |
WO2015185979A1 (fr) | Compositions ano-rectales comprenant un anesthésique sous forme de base libre et un vasoconstricteur sous forme de sel | |
WO2022163694A1 (fr) | Composition pour application externe | |
BR112020012195A2 (pt) | composições e métodos para prevenir e tratar condições | |
JP3568881B2 (ja) | 皮膚疾患治療用外用剤 | |
GB2596286A (en) | Topical formulations containing a primary active and ancillary actives | |
JP3538367B2 (ja) | 皮膚組織障害治療・予防・改善用外用剤 | |
CN114585363A (zh) | 新型儿科组合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Discontinued |
Effective date: 20190501 |